OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens...
23 insider purchases on record · latest filing 2025-11-10.
Insiders have also filed 33 sale transactions at OABI.